Chronic Kidney Disease | Current Treatment | US | 2016
The United States has seen a dramatic rise in the prevalence of chronic kidney disease (CKD) and its sequelae—namely, diabetes and hypertension. Patients with CKD are typically co-managed by many different physician types, including nephrologists, endocrinologists, and primary care physicians (PCPs). Understanding referrals patterns between these physicians for both early- and late-stage CKD patients generates greater insight into patient management, including treatment and prescribing practices. This content stream explores how early- and late-stage CKD-ND patients are referred, co-managed, diagnosed, and treated.
Related Market Assessment Reports
Report
Immune Thrombocytopenic Purpura – Current treatment – Treatment Algorithms: Claims Data Analysis – Immune Thrombocytopenic Purpura (US)
Immune thrombocytopenic purpura (ITP) is an autoimmune disorder characterized by a low platelet count, resulting in an increased risk of bleeding. Current therapies for ITP can be largely divided…
Report
Chronic Urticaria – Current Treatment – Treatment Algorithms: Claims Data Analysis – Chronic Spontaneous Urticaria (US)
The treatment landscape for chronic spontaneous urticaria (CSU) remains largely driven by oral therapies, including approved antihistamines and off-label agents such as DMARDs and…
